Snake venom preparation for drug-resistant human immunodeficiency virus.
Resistance of human immunodeficiency virus to antiretroviral therapy is a major concern. As new therapies are few, progress to acquired immune deficiency syndrome will ensue. We report a patient with multidrug-resistant HIV, high viral load, and low CD4 count who took a snake venom preparation while maintained on antiretroviral therapy. The response was impressive with a decreased viral load and increased CD4 count that was maintained for one year.
Section of Infectious Diseases, Department of Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia. rajhi@kfshrc.edu.sa
Abdulrahman A
AA
Alrajhi
Abdullah
A
Almohaizeie
D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D024882:Drug Resistance, Viral / Q000235:genetics; D005838:Genotype; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D012910:Snake Venoms / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D012910:Snake Venoms